FBInvestor
Stocks / Regeneron Pharmaceuticals
Institutional Ownership

Regeneron Pharmaceuticals

CUSIP 75886F107COMREGNQ1 2026

Insider Transactions
162
Form 4 lines on record
Reporting Insiders
19
Distinct officers & directors
90d Buys
0
Open-market purchase shares
90d Sells
200
Open-market sale shares

Insider Transactions — Form 4

162 reported transactions

Export CSV — Pro
#DateInsiderTitleTypeSharesPriceValueHeld AfterFiling
1Jul 2, 2026Ryan Arthur FDirectorS · Sell200$650.15$130.0K17.3KSEC
2May 1, 2026Ryan Arthur FDirectorS · Sell5$701.76$3.5K17.6KSEC
3May 1, 2026Ryan Arthur FDirectorS · Sell15$702.46$10.5K17.6KSEC
4May 1, 2026Ryan Arthur FDirectorS · Sell24$703.46$16.9K17.6KSEC
5May 1, 2026Ryan Arthur FDirectorS · Sell15$704.28$10.6K17.5KSEC
6May 1, 2026Ryan Arthur FDirectorS · Sell14$705.56$9.9K17.5KSEC
7May 1, 2026Ryan Arthur FDirectorS · Sell7$706.74$4.9K17.5KSEC
8May 1, 2026Ryan Arthur FDirectorS · Sell4$707.40$2.8K17.5KSEC
9May 1, 2026Ryan Arthur FDirectorS · Sell6$709.45$4.3K17.5KSEC
10May 1, 2026Ryan Arthur FDirectorS · Sell2$710.87$1.4K17.5KSEC

152 more insider transactions on Premium

See the full Form 4 transaction history for Regeneron Pharmaceuticals.

Unlock all transactions